Skip to main content
Ganesh Benzoplast Ltd. logo

Ganesh Benzoplast Ltd. — Investor Relations & Filings

Ticker · GANESHBE ISIN · INE388A01029 LEI · 335800ADMLACZ4KJML55 BSE.NS Transportation and storage
Open in API
Filings indexed 927 across all filing types
Latest filing 2023-11-03 Regulatory Filings
Country IN India
Listing BSE.NS GANESHBE

About Ganesh Benzoplast Ltd.

https://www.ganeshbenzoplast.com/

Ganesh Benzoplast Ltd. operates as an independent liquid storage tank provider and a manufacturer of specialty chemicals. The company manages a comprehensive network of bulk liquid storage terminals at major ports, offering infrastructure for the handling and storage of liquid chemicals, petroleum products, and edible oils. Its chemical manufacturing division focuses on the production of food preservatives, specifically sodium benzoate, alongside lubricant additives and plasticizers. The organization provides critical logistics support through its storage facilities and supplies chemical components to the food, automotive, and industrial sectors. By integrating port-based storage solutions with chemical production, the company maintains a significant presence in the midstream logistics and specialty chemical supply chains.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges about a scheduled conference call to discuss the company's un-audited financial results for the quarter ended September 30, 2023. It includes details about the date, time, agenda, and dial-in numbers for the call. The document does not contain actual financial data or the transcript of the call, but rather serves as a notification of the upcoming event. According to the classification rules, such notifications about conference calls are best classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an announcement of the call, it does not fit CT. It is also not a report or earnings release itself. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the conference call event.
2023-11-03 English
Intimation of Conference Call on Thursday November 09, 2023 at 1.00 pm
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges about a scheduled conference call to discuss the company's unaudited financial results for the quarter ended September 30, 2023. It includes details about the date, time, agenda, and dial-in numbers for the call. The document does not contain actual financial data or detailed financial analysis but serves as a notice or invitation for the conference call. According to the classification rules, such a document announcing a conference call is best classified as a Call Transcript (CT) category, as it relates directly to a conference call event. However, since this document is only an announcement/intimation of the conference call and not the transcript itself, it does not fit the CT category. It is also not a report publication announcement (RPA) because it does not mention a report being attached or published. Given the options, the best fit is Regulatory Filings (RNS) as a general regulatory announcement about the conference call. Confidence is high due to clear identification of the document as a conference call intimation without actual financial content.
2023-11-03 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, announcing an arbitration award in favor of the company. It details the arbitration case, the opposing party, the tribunal, and the financial implications of the award. The document is a formal announcement to stock exchanges (BSE and NSE) about a legal/arbitration outcome affecting the company. It does not contain financial statements, management discussion, or detailed financial results. It is not a full audit report or annual/interim report. The content fits best under Legal Proceedings Report (LTR) as it updates on a significant legal/arbitration matter involving the company.
2023-11-01 English
Disclosure Under regulation 30 of SEBI (LODR)Regulations, 2015-Arbitration Award in Favour of the Company
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (BSE and NSE) disclosing an arbitration award in favor of the company. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content details the arbitration award amount and related financial implications but does not contain financial statements or detailed financial analysis. The document length is 3475 characters, which is relatively short and consistent with a regulatory disclosure rather than a full report. There is no indication that this is a full audit report, annual report, earnings release, or other detailed financial report. Instead, it is a regulatory announcement about a legal/arbitration outcome affecting the company. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-11-01 English
Board Meeting — GANESH BENZOPLAST LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2023-10-27 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) notifying them of an upcoming Board Meeting scheduled for November 7, 2023. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2023. The letter references compliance with SEBI Listing Regulations, specifically Regulation 29(1)(a) which pertains to intimation of Board Meetings. The document does not contain any financial data or results itself, but is an announcement of a future event where financial results will be approved. The document length is short (1476 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification of a Board Meeting, not the actual Interim Report or Earnings Release.
2023-10-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.